Citation Impact
Citing Papers
VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia
2003 Standout
Differential response of primary tumor versus lymphatic metastasis to VEGFR-2 and VEGFR-3 kinase inhibitors cediranib and vandetanib
2008
Species Interactions in a Parasite Community Drive Infection Risk in a Wildlife Population
2010 StandoutScience
Vascular Endothelial Growth Factor-A Promotes Peritumoral Lymphangiogenesis and Lymphatic Metastasis
2005
Tumor-Secreted Vascular Endothelial Growth Factor-C Is Necessary for Prostate Cancer Lymphangiogenesis, but Lymphangiogenesis Is Unnecessary for Lymph Node Metastasis
2005
Hallmarks of Cancer: The Next Generation
2011 Standout
ErbB2 overexpression correlates with increased expression of vascular endothelial growth factors A, C, and D in human breast carcinoma
2002
The Lymphangiogenic Vascular Endothelial Growth Factors VEGF-C and -D Are Ligands for the Integrin α9β1
2004
Platelet factor 4–induced T H 1-T reg polarization suppresses antitumor immunity
2024 StandoutScienceNobel
LYVE-1, the lymphatic system and tumor lymphangiogenesis
2001
EGFR Antagonists in Cancer Treatment
2008 Standout
Lymphangiogenesis and cancer metastasis
2002 Standout
Lymphangiogenesis and tumor metastasis
2003
Identification of Vascular Lineage-Specific Genes by Transcriptional Profiling of Isolated Blood Vascular and Lymphatic Endothelial Cells
2003
Molecular mechanisms of lymphangiogenesis in health and disease
2002
Expression of vascular endothelial growth factor family members in head and neck squamous cell carcinoma correlates with lymph node metastasis
2001
Focus on lymphangiogenesis in tumor metastasis
2005
Pathogenesis of persistent lymphatic vessel hyperplasia in chronic airway inflammation
2005 Standout
Concurrent Induction of Lymphangiogenesis, Angiogenesis, and Macrophage Recruitment by Vascular Endothelial Growth Factor-C in Melanoma
2001
Optical microcavities
2003 StandoutNature
VEGF‐C induced lymphangiogenesis is associated with lymph node metastasis in orthotopic MCF‐7 tumors
2002
Hepatocyte growth factor promotes lymphatic vessel formation and function
2005
Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis
2001 Standout
Intratumoral T Cells, Recurrence, and Survival in Epithelial Ovarian Cancer
2003 Standout
Cell Signaling by Receptor Tyrosine Kinases
2010 Standout
VEGF-receptor signal transduction
2003
Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex
2004 StandoutNobel
Cancer Metastasis: Building a Framework
2006 Standout
Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3
2001
New insights into the biology and pathology of the cutaneous lymphatic system
2003
Lymphatics at the crossroads of angiogenesis and lymphangiogenesis
2004
Ranibizumab for Neovascular Age-Related Macular Degeneration
2006 Standout
Genesis and pathogenesis of lymphatic vessels
2003
An essential role for Prox1 in the induction of the lymphatic endothelial cell phenotype
2002 Standout
Molecular lymphangiogenesis: new players
2005
New insights into nNOS regulation of vascular homeostasis
2005 StandoutNobel
Characterization of indolinones which preferentially inhibit VEGF‐C‐ and VEGF‐D‐induced activation of VEGFR‐3 rather than VEGFR‐2
2001
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
Tumor Metastasis: Molecular Insights and Evolving Paradigms
2011 Standout
Functional polarization of tumour-associated macrophages by tumour-derived lactic acid
2014 StandoutNature
Vascular Endothelial Growth Factor and Angiogenesis
2004 Standout
Angiogenesis in cancer and other diseases
2000 StandoutNature
The Hallmarks of Cancer
2000 Standout
Expression of Vascular Endothelial Growth Factor Receptor 1 in Bone Marrow-derived Mesenchymal Cells Is Dependent on Hypoxia-inducible Factor 1
2006 StandoutNobel
Mutations in the Transcription Factor Gene SOX18 Underlie Recessive and Dominant Forms of Hypotrichosis-Lymphedema-Telangiectasia
2003
Specialization of tumour vasculature
2002
ESDN, a Novel Neuropilin-like Membrane Protein Cloned from Vascular Cells with the Longest Secretory Signal Sequence among Eukaryotes, Is Up-regulated after Vascular Injury
2001 StandoutNobel
Lymphatic vasculature development
2004
Mouse LYVE-1 Is an Endocytic Receptor for Hyaluronan in Lymphatic Endothelium
2001
Bevacizumab plus Radiotherapy–Temozolomide for Newly Diagnosed Glioblastoma
2014 Standout
Signalling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic mice
2001
Tumor Lymphangiogenesis
2003
Lymphangiogenesis in development and human disease
2005 StandoutNature
Structural and functional features of central nervous system lymphatic vessels
2015 StandoutNature
Localization of vascular endothelial growth factor-D in malignant melanoma suggests a role in tumour angiogenesis
2001
Ligand-induced Vascular Endothelial Growth Factor Receptor-3 (VEGFR-3) Heterodimerization with VEGFR-2 in Primary Lymphatic Endothelial Cells Regulates Tyrosine Phosphorylation Sites
2003
Survey of the year 2000 commercial optical biosensor literature
2001
Intratumoral Lymphatic Vessels: A Case of Mistaken Identity or Malfunction?
2002
Lymphangiogenic growth factors, receptors and therapies
2003
Angiogenesis in life, disease and medicine
2005 StandoutNature
Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins
2003 Standout
Biology of the lymphatic marker LYVE‐1 and applications in research into lymphatic trafficking and lymphangiogenesis
2004
Analysis of Biological Effects and Signaling Properties of Flt-1 (VEGFR-1) and KDR (VEGFR-2)
2001
Novel VEGF family members: VEGF-B, VEGF-C and VEGF-D
2001
Autologous Chemotaxis as a Mechanism of Tumor Cell Homing to Lymphatics via Interstitial Flow and Autocrine CCR7 Signaling
2007
Emerging mechanisms of tumour lymphangiogenesis and lymphatic metastasis
2005
Identification and expansion of human colon-cancer-initiating cells
2006 StandoutNature
Suppression of Tumor Lymphangiogenesis and Lymph Node Metastasis by Blocking Vascular Endothelial Growth Factor Receptor 3 Signaling
2002
Emerging Biological Principles of Metastasis
2017 Standout
Mechanisms of angiogenesis and their use in the inhibition of tumor growth and metastasis
2000
Organogenesis of peripheral lymphoid organs
2003
Vascular-specific growth factors and blood vessel formation
2000 StandoutNature
Functional significance of vascular endothelial growth factor receptors on gastrointestinal cancer cells
2007
The interaction of Neuropilin-1 with Vascular Endothelial Growth Factor and its receptor Flt-1
2000
Current views on the function of the lymphatic vasculature in health and disease
2010
PDGF-BB induces intratumoral lymphangiogenesis and promotes lymphatic metastasis
2004
Neuropilin is a Mediator of Angiogenesis
2000
The rediscovery of the lymphatic system: old and new insights into the development and biological function of the lymphatic vasculature
2002
Clinical applications of angiogenic growth factors and their inhibitors
1999
Survey of the year 2003 commercial optical biosensor literature
2004
Molecular regulation of lymphangiogenesis and targets for tissue oedema
2001
Innate production of TH2 cytokines by adipose tissue-associated c-Kit+Sca-1+ lymphoid cells
2009 StandoutNature
Sox18 induces development of the lymphatic vasculature in mice
2008 StandoutNature
Genetic dissection of tumor angiogenesis: are PlGF and VEGFR-1 novel anti-cancer targets?
2003
Gene therapy for therapeutic angiogenesis in critically ischaemic lower limb – on the way to the clinic
2001
Design of a Variant of Vascular Endothelial Growth Factor-A (VEGF-A) Antagonizing KDR/Flk-1 and Flt-1
2002
Basic and Therapeutic Aspects of Angiogenesis
2011 Standout
Signaling transduction mechanisms mediating biological actions of the vascular endothelial growth factor family
2001
Optical biosensors in drug discovery
2002
Vascular Endothelial Growth Factor-C and Vascular Endothelial Growth Factor-D mRNA Expression in Breast Cancer: Association with Lymph Node Metastasis
2003
Lymphangiogenesis and lymphatic metastasis in breast cancer
2009
Macrophage biology in development, homeostasis and disease
2013 StandoutNature
Vascular endothelial growth factor receptor‐2: Its unique signaling and specific ligand, VEGF‐E
2003
Cancer-related inflammation
2008 StandoutNature
The Specificity of Receptor Binding by Vascular Endothelial Growth Factor-D Is Different in Mouse and Man
2001
Molecular mechanisms and clinical applications of angiogenesis
2011 StandoutNature
Targeting endothelial and tumor cells with semaphorins
2007
VEGF in Signaling and Disease: Beyond Discovery and Development
2019 Standout
Tumors as Organs: Complex Tissues that Interface with the Entire Organism
2010
Angiogenesis as a therapeutic target
2005 StandoutNature
A system for quantifying the patterning of the lymphatic vasculature
2007
A tumor-homing peptide with a targeting specificity related to lymphatic vessels
2002
Novel Expression of Vascular Endothelial Growth Factor Receptor (VEGFR)-3 and VEGF-C on Corneal Dendritic Cells
2003
Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF-C/D receptor VEGFR-3
2001
VEGFs, receptors and angiogenesis
1999
Defining and using immune archetypes to classify and treat cancer
2023
Snake Venom Vascular Endothelial Growth Factors (VEGFs) Exhibit Potent Activity through Their Specific Recognition of KDR (VEGF Receptor 2)
2003
Vascular Growth Factors and Lymphangiogenesis
2002
Macrophages define dermal lymphatic vessel calibre during development by regulating lymphatic endothelial cell proliferation
2010
Molecular Biology and Pathology of Lymphangiogenesis
2008 Standout
Structural determinants of growth factor binding and specificity by VEGF receptor 2
2010
Abnormal lymphatic vessel development in neuropilin 2 mutant mice
2002
Preexisting Lymphatic Endothelium but not Endothelial Progenitor Cells Are Essential for Tumor Lymphangiogenesis and Lymphatic Metastasis
2004
VEGF-A induces tumor and sentinel lymph node lymphangiogenesis and promotes lymphatic metastasis
2005
Vascular Endothelial Cell Growth Factor Receptor 3–Mediated Activation of Lymphatic Endothelium Is Crucial for Tumor Cell Entry and Spread via Lymphatic Vessels
2005
Directed and Systematic Differentiation of Cardiovascular Cells From Mouse Induced Pluripotent Stem Cells
2008 StandoutNobel
Vascular Endothelial Growth Factor: Basic Science and Clinical Progress
2004 Standout
Mechanisms of lymphatic metastasis
2014
Intratumoral lymphangiogenesis and lymph node metastasis in head and neck cancer.
2002
Vascular Endothelial Growth Factor (VEGF) and VEGF-C Show Overlapping Binding Sites in Embryonic Endothelia and Distinct Sites in Differentiated Adult Endothelia
1999
Lymphatic Metastasis in the Absence of Functional Intratumor Lymphatics
2002 StandoutScience
Getting out and about: the emergence and morphogenesis of the vertebrate lymphatic vasculature
2013
A repressor sequence in the juxtamembrane domain of Flt-1 (VEGFR-1) constitutively inhibits vascular endothelial growth factor-dependent phosphatidylinositol 3′-kinase activation and endothelial cell migration
2000
Vascular Endothelial Growth Factor D Is Dispensable for Development of the Lymphatic System
2005
Isolation and Characterization of Dermal Lymphatic and Blood Endothelial Cells Reveal Stable and Functionally Specialized Cell Lineages
2001
The Angiogenic and Lymphangiogenic Factor Vascular Endothelial Growth Factor-D Exhibits a Paracrine Mode of Action in Cancer
2002
VEGFR-3 and CD133 identify a population of CD34+ lymphatic/vascular endothelial precursor cells
2002
Pathogenesis of persistent lymphatic vessel hyperplasia in chronic airway inflammation
2005
Adenoviral Expression of Vascular Endothelial Growth Factor-C Induces Lymphangiogenesis in the Skin
2001
Angiogenesis in Ischemic Disease
1999
Lymphangiogenic Gene Therapy With Minimal Blood Vascular Side Effects
2002
VEGF Receptor Signal Transduction
2001
Mechanically activated ion channel PIEZO1 is required for lymphatic valve formation
2018 StandoutNobel
Blockade of vascular endothelial growth factor receptor-3 signaling inhibits fibroblast growth factor-2-induced lymphangiogenesis in mouse cornea
2002
The Interaction of Neuropilin-1 with Vascular Endothelial Growth Factor and Its Receptor Flt-1
2000
VEGF‐C and VEGF‐D expression in neuroendocrine cells and their receptor, VEGFR‐3, in fenestrated blood vessels in human tissues
2000
Adenovirus encoding vascular endothelial growth factor–D induces tissue-specific vascular patterns in vivo
2002
Hypoxia-inducible factor 1-dependent expression of platelet-derived growth factor B promotes lymphatic metastasis of hypoxic breast cancer cells
2012 StandoutNobel
Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
2005 StandoutScience
Peptide blockade of HIFα degradation modulates cellular metabolism and angiogenesis
2002 StandoutNobel
Poxviruses and Immune Evasion
2003
Surface Plasmon Resonance Sensors for Detection of Chemical and Biological Species
2008 Standout
Selective inhibition of vascular endothelial growth factor (VEGF) receptor 2 (KDR/Flk-1) activity by a monoclonal anti-VEGF antibody blocks tumor growth in mice.
2000
Regulation of angiogenesis via vascular endothelial growth factor receptors.
2000
Angiogenesis in Endocrine Tumors
2003
Plasmin Activates the Lymphangiogenic Growth Factors VEGF-C and VEGF-D
2003
The splice variants of vascular endothelial growth factor (VEGF) and their receptors
2001
Lymphatic Vessels as Targets of Tumor Therapy?
2001
Vascular endothelial growth factor-D expression is an independent prognostic marker for survival in colorectal carcinoma.
2002
VEGF-D Is the Strongest Angiogenic and Lymphangiogenic Effector Among VEGFs Delivered Into Skeletal Muscle via Adenoviruses
2003
Lymphatic endothelium: a new frontier of metastasis research
2002
Role of the Vascular Endothelial Growth Factor Pathway in Tumor Growth and Angiogenesis
2004 Standout
Differential in vivo and in vitro expression of vascular endothelial growth factor (VEGF)-C and VEGF-D in tumors and its relationship to lymphatic metastasis in immunocompetent rats.
2003
Works of Carol Caesar being referenced
CCL27/CCL28–CCR10 Chemokine Signaling Mediates Migration of Lymphatic Endothelial Cells
2019
Biosynthesis of Vascular Endothelial Growth Factor-D Involves Proteolytic Processing Which Generates Non-covalent Homodimers
1999
The 3T3-L1 Fibroblast to Adipocyte Conversion is Accompanied by Increased Expression of Angiopoietin-1, A Ligand for Tie2
2000
VEGF-D promotes the metastatic spread of tumor cells via the lymphatics
2001
A Mutant Form of Vascular Endothelial Growth Factor (VEGF) That Lacks VEGF Receptor-2 Activation Retains the Ability to Induce Vascular Permeability
1999
Viral Vascular Endothelial Growth Factors Vary Extensively in Amino Acid Sequence, Receptor-binding Specificities, and the Ability to Induce Vascular Permeability yet Are Uniformly Active Mitogens
2003
Monoclonal antibodies to vascular endothelial growth factor‐D block its interactions with both VEGF receptor‐2 and VEGF receptor‐3
2000
Vascular endothelial growth factor (VEGF)-like protein from orf virus NZ2 binds to VEGFR2 and neuropilin-1
1999